PL2309983T3 - Farmaceutyczna postać podawania zawierająca tetrahydrobiopterynę - Google Patents
Farmaceutyczna postać podawania zawierająca tetrahydrobiopterynęInfo
- Publication number
- PL2309983T3 PL2309983T3 PL09775591T PL09775591T PL2309983T3 PL 2309983 T3 PL2309983 T3 PL 2309983T3 PL 09775591 T PL09775591 T PL 09775591T PL 09775591 T PL09775591 T PL 09775591T PL 2309983 T3 PL2309983 T3 PL 2309983T3
- Authority
- PL
- Poland
- Prior art keywords
- tetrahydrobiopterin
- pharmaceutical form
- pharmaceutical
- Prior art date
Links
- FNKQXYHWGSIFBK-RPDRRWSUSA-N sapropterin Chemical compound N1=C(N)NC(=O)C2=C1NC[C@H]([C@@H](O)[C@@H](O)C)N2 FNKQXYHWGSIFBK-RPDRRWSUSA-N 0.000 title 1
- 229960004617 sapropterin Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AT12542008 | 2008-08-12 | ||
| PCT/AT2009/000306 WO2010017570A2 (de) | 2008-08-12 | 2009-08-07 | Pharmazeutische darreichungsform enthaltend tetrahydrobiopterin |
| EP09775591.2A EP2309983B1 (de) | 2008-08-12 | 2009-08-07 | Pharmazeutische darreichungsform enthaltend tetrahydrobiopterin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2309983T3 true PL2309983T3 (pl) | 2019-09-30 |
Family
ID=41111155
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL09775591T PL2309983T3 (pl) | 2008-08-12 | 2009-08-07 | Farmaceutyczna postać podawania zawierająca tetrahydrobiopterynę |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20110144117A1 (pl) |
| EP (1) | EP2309983B1 (pl) |
| JP (1) | JP2011530540A (pl) |
| ES (1) | ES2736730T3 (pl) |
| PL (1) | PL2309983T3 (pl) |
| RU (1) | RU2011109210A (pl) |
| TR (1) | TR201910287T4 (pl) |
| WO (1) | WO2010017570A2 (pl) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2780032B1 (en) * | 2013-01-10 | 2018-03-28 | Allergy Research Group, LLC | Chewable wafers containing lipid supplements for maintaining health and the treatment of acute and chronic disorders |
| RS54973B1 (sr) | 2014-03-31 | 2016-11-30 | Vasopharm Gmbh | Čvrste farmaceutske kompozicije koje uključuju derivate biopterina i upotreba takvih kompozicija |
| EP3548497A4 (en) | 2016-11-29 | 2020-09-02 | Censa Pharmaceuticals Inc. | SEPIAPTERIN POLYMORPHS AND THEIR SALTS |
| CN110312721A (zh) | 2016-11-29 | 2019-10-08 | 显莎制药公司 | 墨蝶呤的多晶型物 |
| EP3675863A4 (en) * | 2017-09-01 | 2021-01-27 | PTC Therapeutics MP, Inc. | PHARMACEUTICAL COMPOSITIONS WITH SEPIAPTERIN AND USES THEREOF |
| BR112020024329A2 (pt) | 2018-05-30 | 2021-02-23 | Ptc Therapeutics Mp, Inc. | composições e métodos para aumentar exposição de plasma de tetra-hidrobiopterin |
| MD3801536T2 (ro) | 2018-05-30 | 2024-11-30 | Ptc Therapeutics Mp Inc | Administrarea sepiapterinei fără alimente pentru utilizare într-o metodă de creștere a expunerii plasmatice a sepiapterinei |
| JP7553906B2 (ja) * | 2018-11-01 | 2024-09-19 | 宏 一瀬 | Ｓｐｒをコードするポリヌクレオチドを含む組換えベクター、及びそれを含む組成物 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS61277618A (ja) * | 1985-06-04 | 1986-12-08 | Suntory Ltd | 自閉症治療剤 |
| JP2588191B2 (ja) * | 1987-04-24 | 1997-03-05 | サントリー株式会社 | 悪性腫瘍および重症ウイルス感染症に伴う神経症状を改善するための治療剤 |
| DE10260263A1 (de) * | 2002-12-20 | 2004-07-15 | Biocrates Life Sciences Gmbh | Verwendung von Tetrahydrobiopterinderivaten zur Behandlung und Ernährung von Patienten mit Aminosäurestoffwechselstörungen |
| ES2393785T3 (es) * | 2004-05-11 | 2012-12-28 | Daiichi Sankyo Company, Limited | Remedios para hiperfenilalaninemia sensible a BH4 |
| WO2006055511A2 (en) * | 2004-11-17 | 2006-05-26 | Biomarin Pharmaceutical Inc. | Stable tablet formulation of tetrahydrobiopterin |
| US20060188492A1 (en) * | 2005-01-13 | 2006-08-24 | Chronorx Llc, An Alaska Limited Liability Company | Topical management of ocular and periocular conditions |
| WO2006120176A2 (en) * | 2005-05-11 | 2006-11-16 | Nycomed Gmbh | Combination of the pde4 inhibitor roflumilast and a tetrahydrobiopterin derivative |
| HRP20220188T3 (hr) * | 2007-04-11 | 2022-04-29 | Biomarin Pharmaceutical Inc. | Načini primjene tetrahidrobiopterina, povezani pripravci i postupci mjerenja |
-
2009
- 2009-08-07 ES ES09775591T patent/ES2736730T3/es active Active
- 2009-08-07 TR TR2019/10287T patent/TR201910287T4/tr unknown
- 2009-08-07 RU RU2011109210/15A patent/RU2011109210A/ru not_active Application Discontinuation
- 2009-08-07 JP JP2011522346A patent/JP2011530540A/ja active Pending
- 2009-08-07 EP EP09775591.2A patent/EP2309983B1/de active Active
- 2009-08-07 WO PCT/AT2009/000306 patent/WO2010017570A2/de not_active Ceased
- 2009-08-07 PL PL09775591T patent/PL2309983T3/pl unknown
- 2009-08-07 US US13/058,625 patent/US20110144117A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| JP2011530540A (ja) | 2011-12-22 |
| ES2736730T3 (es) | 2020-01-07 |
| TR201910287T4 (tr) | 2019-07-22 |
| EP2309983B1 (de) | 2019-04-24 |
| US20110144117A1 (en) | 2011-06-16 |
| EP2309983A2 (de) | 2011-04-20 |
| RU2011109210A (ru) | 2012-09-20 |
| WO2010017570A2 (de) | 2010-02-18 |
| WO2010017570A3 (de) | 2010-08-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL237391A0 (en) | Pharmaceutical combination | |
| IL228817A0 (en) | Pharmaceutical compounds | |
| IL207378A0 (en) | Pharmaceutical solid state forms | |
| SI2364137T1 (sl) | Farmacevtska suspenzija | |
| ZA201104348B (en) | Pharmaceutical preparation | |
| GB0816371D0 (en) | Pharmaceutical compounds | |
| GB0810615D0 (en) | Novel pharmaceutical | |
| GB0812969D0 (en) | Pharmaceutical compounds | |
| HU0800591D0 (en) | Stable pharmaceutical combination | |
| GB0816370D0 (en) | Pharmaceutical compounds | |
| IL208387A0 (en) | Pharmaceutical composition | |
| PL2309983T3 (pl) | Farmaceutyczna postać podawania zawierająca tetrahydrobiopterynę | |
| GB0815972D0 (en) | Pharmaceutical preparation | |
| IL208953A0 (en) | Pharmaceutical combination | |
| GB0810857D0 (en) | Pharmaceutical compounds | |
| ZA201006224B (en) | Pharmaceutical composition | |
| GB2464200B (en) | Pharmaceutical composition | |
| GB0810617D0 (en) | Novel pharmaceutical | |
| GB0817969D0 (en) | Pharmaceutical composition | |
| HU0800414D0 (en) | Pharmaceutical combination | |
| GB0804486D0 (en) | Novel pharmaceutical composituons | |
| GB0810217D0 (en) | Pharmaceutical formulations | |
| GB0813031D0 (en) | Pharmaceutical formulations | |
| GB0802576D0 (en) | Dosage form | |
| GB0817974D0 (en) | Pharmaceutical composition |